Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants

New England Journal of Medicine - United States
doi 10.1056/nejmoa0807773
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Massachusetts Medical Society

Related search

A Combined Analysis of Immunogenicity, Antibody Kinetics and Vaccine Efficacy From Phase 2 Trials of the RTS,S Malaria Vaccine

BMC Medicine
Medicine
2014English

Pooled Analysis of Safety Data From Pediatric Phase II RTS,S/AS Malaria Candidate Vaccine Trials

Human Vaccines
2011English

Policy Analysis for Deciding on a Malaria Vaccine RTS,S in Tanzania

Malaria Journal
ParasitologyInfectious Diseases
2016English

Combining Antimalarial Drugs and Vaccine for Malaria Elimination Campaigns: A Randomised Safety and Immunogenicity Trial of RTS,S/AS01 Administered With Dihydroartemisinin, Piperaquine and Primaquine in Healthy Thai Adult Volunteers

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

CNS Infection Safety Signal of RTS,S/AS01 and Possible Association With Rabies Vaccine

The Lancet
Medicine
2016English

Efficacy and Safety of RTS,S/AS01 Malaria Vaccine With or Without a Booster Dose in Infants and Children in Africa: Final Results of a Phase 3, Individually Randomised, Controlled Trial

The Lancet
Medicine
2015English

Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area

PLoS ONE
Multidisciplinary
2009English

Characterization of T-Cell Immune Responses in Clinical Trials of the Candidate RTS,S Malaria Vaccine

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2017English

The RTS,S/AS01 Malaria Vaccine in Children 5 to 17 Months of Age at First Vaccination

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy